A phase III concurrent chemoradiotherapy trial with cisplatin and paclitaxel or docetaxel or gemcitabine in unresectable non-small cell lung cancer: KASLC 0401.
about
Definitive Bimodality Concurrent Chemoradiotherapy in Patients with Inoperable N2-positive Stage IIIA Non-small Cell Lung Cancer.Delineation of clinical target volume for postoperative radiotherapy in stage IIIA-pN2 non-small-cell lung cancerPhase III study of cisplatin with pemtrexed or vinorelbine plus concurrent late course accelerated hyperfractionated radiotherapy in patients with unresectable stage III non-small cell lung cancer.Aurora B expression modulates paclitaxel response in non-small cell lung cancer.Trial Watch: Radioimmunotherapy for oncological indications.Phase I study of concurrent and consolidation cisplatin and docetaxel chemotherapy with thoracic radiotherapy in non-small cell lung cancer.
P2860
A phase III concurrent chemoradiotherapy trial with cisplatin and paclitaxel or docetaxel or gemcitabine in unresectable non-small cell lung cancer: KASLC 0401.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
2013年學術文章
@zh-hant
name
A phase III concurrent chemora ...... cell lung cancer: KASLC 0401.
@en
A phase III concurrent chemora ...... cell lung cancer: KASLC 0401.
@nl
type
label
A phase III concurrent chemora ...... cell lung cancer: KASLC 0401.
@en
A phase III concurrent chemora ...... cell lung cancer: KASLC 0401.
@nl
prefLabel
A phase III concurrent chemora ...... cell lung cancer: KASLC 0401.
@en
A phase III concurrent chemora ...... cell lung cancer: KASLC 0401.
@nl
P2093
P2860
P1476
A phase III concurrent chemora ...... cell lung cancer: KASLC 0401.
@en
P2093
Hee-Jung Ban
Joo-Young Song
Kyu-Sik Kim
Mee-Sun Yoon
Sung-Chul Lim
Sung-Ja Ahn
Taek-Keun Nam
Woong-Ki Chung
Yong-Soo Kwon
P2860
P2888
P304
P356
10.1007/S00280-013-2308-5
P577
2013-10-05T00:00:00Z